Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation
Journal of the American Society of Nephrology · 2026-11 · 37 (11) · 2517-2528
DOI: 10.1681/asn.0000001133 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 16.06.2026. Verfasst von Jeffrey A Klein und 53 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas, Kansas City, Kansas. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Graft Rejection, Kidney Transplantation. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CareDx, Inc. (Brisbane, California, USA).
Abstract (Originalsprache)
Key Points We assessed whether an initial donor-derived cell-free DNA elevation during routine surveillance was associated with allograft dysfunction and loss in kidney transplant recipients. Intermediate and high donor-derived cell-free DNA states were independently associated with 3.7-fold and 6.4-fold higher risks of allograft loss, respectively. Persistently low donor-derived cell-free DNA levels were associated with low rates of rejection and allograft loss, identifying a low-risk population.
Background
Although donor-derived cell-free DNA (dd-cfDNA) correlates with histologic rejection and injury severity, its association with long-term graft outcomes has yet to be well established in kidney transplant recipients. We hypothesize that among patients monitored with dd-cfDNA, an initial elevation may be associated with subsequent allograft dysfunction and loss.
Methods
The Kidney Allograft Outcomes AlloSure Registry is a prospective, multicenter cohort of 1743 adult kidney transplant recipients from 56 US centers; this analysis included 1258 patients who initiated dd-cfDNA surveillance 15–60 days post-transplant with up to 3-year follow-up. A multistate model was applied to characterize transitions from a low dd-cfDNA state (no elevations) to intermediate (0.5%–1.0% with ≥61% relative change value) or high (≥1.0%) dd-cfDNA states, and their unadjusted and covariate-adjusted associations with allograft loss or all-cause death were quantified using hazard regression models.
Results
Within 3 years, 36% of patients transitioned to an elevated dd-cfDNA state (intermediate n =216; high n =233). Allograft dysfunction by 36 months occurred significantly more often in patients with dd-cfDNA elevations despite preserved allograft function at the time of elevation (eGFR ≥60 ml/min per 1.73 m 2 in 42% of intermediate and 33% of high), consistent with subclinical injury. Transitions from low to elevated dd-cfDNA states were strongly associated with subsequent allograft loss (adjusted hazard ratios, 3.70 [95% confidence interval [CI], 1.38 to 9.90] for intermediate; 6.36 [95% CI, 2.80 to 14.42] for high), while mortality did not differ by dd-cfDNA state.
Conclusions
Initial dd-cfDNA elevations exceeding established thresholds were independently associated with higher risks of allograft dysfunction and loss across both elevation categories, whereas patients who remained in the low dd-cfDNA state experienced favorable outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas, Kansas City, Kansas.
- Department of Surgery, Medical University of South Carolina, Charleston, South Carolina.
- Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas.
- Department of Medicine, University of Wisconsin Hospital, Madison, Wisconsin.
- CareDx, Inc, Brisbane, California.
- Department of Surgery, Rush University Medical Center, Chicago, Illinois.
ORCID-Profile: Jeffrey A Klein, David Taber, David Wojciechowski, Didier A Mandelbrot, Renata Glehn-Ponsirenas, Pranjal Jain, James Lu, Martina M McGrath, Mohanram Narayanan, Anup M Patel, Massini Merzkani, Nitipong Permpalung, Rashikh A Choudhury, Michelle A Josephson, Sanjiv Anand, Pradeep Vaitla, Eric Langewisch, Maria Ajaimy, Dhiren Kumar, George W Burke, Todd E Pesavento, Anthony J Langone, Yihung Huang, David Leeser, Bernard Fischbach, Nadiesda Costa, Kalathil Sureshkumar, Chun-Po Steve Fan, Ziad Zaky, Fuad Shihab, Sanjay Kulkarni, Thin Thin Maw, Bekir Tanriover, Enver Akalin, Matthew Cooper, Ibrahim Tawhari, Matthew R Weir, Tarek Alhamad, Daniel C Brennan, Nicolae Leca, Suphamai Bunnapradist, Ling Shen, Peale Chuang, Prince Anand, Emilio D Poggio, Giselle Guerra, Alexander Wiseman, Anil Paramesh, Diane Cibrik, Jonathan Bromberg
Förderung
- CareDx, Inc. (Brisbane, California, USA)
Zitieren
APA
Klein, J. A., Taber, D., Wojciechowski, D., Mandelbrot, D. A., Glehn-Ponsirenas, R., Olaitan, O., Jain, P., Lu, J., McGrath, M. M., Narayanan, M., Patel, A. M., Merzkani, M., Permpalung, N., Choudhury, R. A., Josephson, M. A., Anand, S., Vaitla, P., Langewisch, E., Ajaimy, M., …, & KOAR Study Investigators (2026). Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation. Journal of the American Society of Nephrology, 37(11), 2517-2528. https://doi.org/10.1681/asn.0000001133
Vancouver
Klein JA, Taber D, Wojciechowski D, Mandelbrot DA, Glehn-Ponsirenas R, Olaitan O, et al. Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation. Journal of the American Society of Nephrology. 2026;37(11):2517-2528. doi:10.1681/asn.0000001133
BibTeX
@article{Klein2026,
author = {Klein, Jeffrey A and Taber, David and Wojciechowski, David and Mandelbrot, Didier A and Glehn-Ponsirenas, Renata and Olaitan, Oyedolamu and Jain, Pranjal and Lu, James and McGrath, Martina M and Narayanan, Mohanram and Patel, Anup M and Merzkani, Massini and Permpalung, Nitipong and Choudhury, Rashikh A and Josephson, Michelle A and Anand, Sanjiv and Vaitla, Pradeep and Langewisch, Eric and Ajaimy, Maria and Kumar, Dhiren and Burke, George W and Pesavento, Todd E and Langone, Anthony J and Huang, Yihung and Leeser, David and Fischbach, Bernard and Costa, Nadiesda and Sureshkumar, Kalathil and Qannus, Abd A and Fan, Chun-Po Steve and Zaky, Ziad and Shihab, Fuad and Kulkarni, Sanjay and Maw, Thin Thin and Tanriover, Bekir and Akalin, Enver and Cooper, Matthew and Tawhari, Ibrahim and Weir, Matthew R and Alhamad, Tarek and Brennan, Daniel C and Leca, Nicolae and Bunnapradist, Suphamai and Shen, Ling and Woodward, Robert N and Chuang, Peale and Anand, Prince and Poggio, Emilio D and Guerra, Giselle and Wiseman, Alexander and Paramesh, Anil and Cibrik, Diane and Bromberg, Jonathan and KOAR Study Investigators, KOAR Study Investigators},
title = {Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {11},
pages = {2517--2528},
doi = {10.1681/asn.0000001133}
}
EUVIMED